128 results on '"Lackner N"'
Search Results
2. MO-0550 Correlations between cerebral cortical thickness, radiation dose and verbal memory performance
- Author
-
Budé, I., de Jong, J., Lackner, N., Drenthen, G.S., van Elmpt, W., Backes, W., Postma, A.A., Dijkstra, J.B., Compter, I., Eekers, D.B., and Zegers, C.M.
- Published
- 2023
- Full Text
- View/download PDF
3. PO-1640 Advanced 3D printing for heterogeneous and dynamic phantoms for dosimetry and imaging
- Author
-
Paiva Fonseca, G., primary, Bellezzo, M., additional, Voncken, R., additional, Rezaeifar, B., additional, van Wagenberg, T., additional, Lackner, N., additional, and Verhaegen, F., additional
- Published
- 2022
- Full Text
- View/download PDF
4. Stress bei bipolar affektiver Störung
- Author
-
Reininghaus, E.Z., Zelzer, S., Reininghaus, B., Lackner, N., Birner, A., Bengesser, S.A., Fellendorf, F.T., Kapfhammer, H.-P., and Mangge, H.
- Published
- 2014
- Full Text
- View/download PDF
5. Public health as common goal or individual constraint in winter tourism of Tyrol and Vorarlberg
- Author
-
Kerschbaumer, L, primary, Walch, S, additional, Sahling, F, additional, Reisberger, M, additional, Mevenkamp, N, additional, Mantel, C, additional, Lackner, N, additional, Luttinger, P, additional, and Pejkovic, E, additional
- Published
- 2021
- Full Text
- View/download PDF
6. PD-0827 Development of target-optimized CBCT imaging to reduce imaging dose and improve image quality
- Author
-
Lackner, N., primary, van der Heyden, B., additional, Messner, I.M., additional, Steininger, P., additional, Zechner, A., additional, Ableitinger, A., additional, Stock, M., additional, Fonseca, G., additional, and Verhaegen, F., additional
- Published
- 2021
- Full Text
- View/download PDF
7. OC-0577: Impact of beamline-specific particle energy spectra on clinical plans in carbon ion beam therapy
- Author
-
Resch, A., primary, Lackner, N., additional, Niessen, T., additional, Engdahl, S., additional, Elia, A., additional, Boersma, D., additional, Grevillot, L., additional, Fuchs, H., additional, Kragl, G., additional, Glimelius, L., additional, Georg, D., additional, Stock, M., additional, and Carlino, A., additional
- Published
- 2020
- Full Text
- View/download PDF
8. Effects of multipurpose contact lens solutions on the protein composition of the tear film
- Author
-
Grus, Franz H., Kramann, C., Bozkurt, N., Wiegel, N., Bruns, K., Lackner, N., and Pfeiffer, Norbert
- Published
- 2005
- Full Text
- View/download PDF
9. Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study
- Author
-
Kalman, JL, Papiol, S, Forstner, AJ, Heilbronner, U, Degenhardt, F, Strohmaier, J, Adli, M, Adorjan, K, Akula, N, Alda, M, Anderson-Schmidt, H, Andlauer, TFM, Anghelescu, IG, Ardau, R, Arias, B, Arolt, V, Aubry, JM, Backlund, L, Bartholdi, K, Bauer, M, Baune, BT, Becker, T, Bellivier, F, Benabarre, A, Bengesser, S, Bhattacharjee, AK, Biernacka, JM, Birner, A, Brichant-Petitjean, C, Budde, M, Cervantes, P, Chillotti, C, Cichon, S, Clark, SR, Colom, F, Comes, AL, Cruceanu, C, Czerski, PM, Dannlowski, U, Dayer, A, Del Zompo, M, DePaulo, JR, Dietrich, DE, Étain, B, Ethofer, T, Falkai, P, Fallgatter, A, Figge, C, Flatau, L, Folkerts, H, Frisen, L, Frye, MA, Fullerton, JM, Gade, K, Gard, S, Garnham, JS, Goes, FS, Grigoroiu-Serbanescu, M, Gryaznova, A, Hake, M, Hauser, J, Herms, S, Hoffmann, P, Hou, L, Jäger, M, Jamain, S, Jiménez, E, Juckel, G, Kahn, JP, Kassem, L, Kelsoe, J, Kittel-Schneider, S, Kliwicki, S, Klohn-Sagatholislam, F, Koller, M, König, B, Konrad, C, Lackner, N, Laje, G, Landén, M, Lang, FU, Lavebratt, C, Leboyer, M, Leckband, SG, Maj, M, Manchia, M, Martinsson, L, McCarthy, MJ, McElroy, SL, McMahon, FJ, Mitchell, PB, Mitjans, M, Mondimore, FM, Monteleone, P, Nieratschker, V, Nievergelt, CM, Novák, T, Ösby, U, Pfennig, A, Potash, JB, Kalman, JL, Papiol, S, Forstner, AJ, Heilbronner, U, Degenhardt, F, Strohmaier, J, Adli, M, Adorjan, K, Akula, N, Alda, M, Anderson-Schmidt, H, Andlauer, TFM, Anghelescu, IG, Ardau, R, Arias, B, Arolt, V, Aubry, JM, Backlund, L, Bartholdi, K, Bauer, M, Baune, BT, Becker, T, Bellivier, F, Benabarre, A, Bengesser, S, Bhattacharjee, AK, Biernacka, JM, Birner, A, Brichant-Petitjean, C, Budde, M, Cervantes, P, Chillotti, C, Cichon, S, Clark, SR, Colom, F, Comes, AL, Cruceanu, C, Czerski, PM, Dannlowski, U, Dayer, A, Del Zompo, M, DePaulo, JR, Dietrich, DE, Étain, B, Ethofer, T, Falkai, P, Fallgatter, A, Figge, C, Flatau, L, Folkerts, H, Frisen, L, Frye, MA, Fullerton, JM, Gade, K, Gard, S, Garnham, JS, Goes, FS, Grigoroiu-Serbanescu, M, Gryaznova, A, Hake, M, Hauser, J, Herms, S, Hoffmann, P, Hou, L, Jäger, M, Jamain, S, Jiménez, E, Juckel, G, Kahn, JP, Kassem, L, Kelsoe, J, Kittel-Schneider, S, Kliwicki, S, Klohn-Sagatholislam, F, Koller, M, König, B, Konrad, C, Lackner, N, Laje, G, Landén, M, Lang, FU, Lavebratt, C, Leboyer, M, Leckband, SG, Maj, M, Manchia, M, Martinsson, L, McCarthy, MJ, McElroy, SL, McMahon, FJ, Mitchell, PB, Mitjans, M, Mondimore, FM, Monteleone, P, Nieratschker, V, Nievergelt, CM, Novák, T, Ösby, U, Pfennig, A, and Potash, JB
- Abstract
Objectives: Bipolar disorder (BD) with early disease onset is associated with an unfavorable clinical outcome and constitutes a clinically and biologically homogenous subgroup within the heterogeneous BD spectrum. Previous studies have found an accumulation of early age at onset (AAO) in BD families and have therefore hypothesized that there is a larger genetic contribution to the early-onset cases than to late onset BD. To investigate the genetic background of this subphenotype, we evaluated whether an increased polygenic burden of BD- and schizophrenia (SCZ)-associated risk variants is associated with an earlier AAO in BD patients. Methods: A total of 1995 BD type 1 patients from the Consortium of Lithium Genetics (ConLiGen), PsyCourse and Bonn-Mannheim samples were genotyped and their BD and SCZ polygenic risk scores (PRSs) were calculated using the summary statistics of the Psychiatric Genomics Consortium as a training data set. AAO was either separated into onset groups of clinical interest (childhood and adolescence [≤18 years] vs adulthood [>18 years]) or considered as a continuous measure. The associations between BD- and SCZ-PRSs and AAO were evaluated with regression models. Results: BD- and SCZ-PRSs were not significantly associated with age at disease onset. Results remained the same when analyses were stratified by site of recruitment. Conclusions: The current study is the largest conducted so far to investigate the association between the cumulative BD and SCZ polygenic risk and AAO in BD patients. The reported negative results suggest that such a polygenic influence, if there is any, is not large, and highlight the importance of conducting further, larger scale studies to obtain more information on the genetic architecture of this clinically relevant phenotype.
- Published
- 2019
10. Erratum zu: Oxidativer Stress bei bipolar affektiver Störung
- Author
-
Reininghaus, E.Z., Zelzer, S., Reininghaus, B., Lackner, N., Birner, A., Bengesser, S.A., Fellendorf, F.T., Kapfhammer, H.-P., and Mangge, H.
- Published
- 2015
- Full Text
- View/download PDF
11. Analysis of the influence of microRNAs in lithium response in bipolar disorder
- Author
-
Reinbold, CS, Forstner, AJ, Hecker, J, Fullerton, JM, Hoffmann, P, Hou, L, Heilbronner, U, Degenhardt, F, Adli, M, Akiyama, K, Akula, N, Ardau, R, Arias, B, Backlund, L, Benabarre, A, Bengesser, S, Bhattacharjee, AK, Biernacka, JM, Birner, A, Marie-Claire, C, Cervantes, P, Chen, GB, Chen, HC, Chillotti, C, Clark, SR, Colom, F, Cousins, DA, Cruceanu, C, Czerski, PM, Dayer, A, Étain, B, Falkai, P, Frisén, L, Gard, S, Garnham, JS, Goes, FS, Grof, P, Gruber, O, Hashimoto, R, Hauser, J, Herms, S, Jamain, S, Jiménez, E, Kahn, JP, Kassem, L, Kittel-Schneider, S, Kliwicki, S, König, B, Kusumi, I, Lackner, N, Laje, G, Landén, M, Lavebratt, C, Leboyer, M, Leckband, SG, Jaramillo, CAL, MacQueen, G, Manchia, M, Martinsson, L, Mattheisen, M, McCarthy, MJ, McElroy, SL, Mitjans, M, Mondimore, FM, Monteleone, P, Nievergelt, CM, Ösby, U, Ozaki, N, Perlis, RH, Pfennig, A, Reich-Erkelenz, D, Rouleau, GA, Schofield, PR, Schubert, KO, Schweizer, BW, Seemüller, F, Severino, G, Shekhtman, T, Shilling, PD, Shimoda, K, Simhandl, C, Slaney, CM, Smoller, JW, Squassina, A, Stamm, TJ, Stopkova, P, Tighe, SK, Tortorella, A, Turecki, G, Volkert, J, Witt, SH, Wright, AJ, Trevor Young, L, Zandi, PP, Potash, JB, DePaulo, JR, Bauer, M, Reininghaus, E, Novák, T, Aubry, JM, Reinbold, CS, Forstner, AJ, Hecker, J, Fullerton, JM, Hoffmann, P, Hou, L, Heilbronner, U, Degenhardt, F, Adli, M, Akiyama, K, Akula, N, Ardau, R, Arias, B, Backlund, L, Benabarre, A, Bengesser, S, Bhattacharjee, AK, Biernacka, JM, Birner, A, Marie-Claire, C, Cervantes, P, Chen, GB, Chen, HC, Chillotti, C, Clark, SR, Colom, F, Cousins, DA, Cruceanu, C, Czerski, PM, Dayer, A, Étain, B, Falkai, P, Frisén, L, Gard, S, Garnham, JS, Goes, FS, Grof, P, Gruber, O, Hashimoto, R, Hauser, J, Herms, S, Jamain, S, Jiménez, E, Kahn, JP, Kassem, L, Kittel-Schneider, S, Kliwicki, S, König, B, Kusumi, I, Lackner, N, Laje, G, Landén, M, Lavebratt, C, Leboyer, M, Leckband, SG, Jaramillo, CAL, MacQueen, G, Manchia, M, Martinsson, L, Mattheisen, M, McCarthy, MJ, McElroy, SL, Mitjans, M, Mondimore, FM, Monteleone, P, Nievergelt, CM, Ösby, U, Ozaki, N, Perlis, RH, Pfennig, A, Reich-Erkelenz, D, Rouleau, GA, Schofield, PR, Schubert, KO, Schweizer, BW, Seemüller, F, Severino, G, Shekhtman, T, Shilling, PD, Shimoda, K, Simhandl, C, Slaney, CM, Smoller, JW, Squassina, A, Stamm, TJ, Stopkova, P, Tighe, SK, Tortorella, A, Turecki, G, Volkert, J, Witt, SH, Wright, AJ, Trevor Young, L, Zandi, PP, Potash, JB, DePaulo, JR, Bauer, M, Reininghaus, E, Novák, T, and Aubry, JM
- Abstract
Bipolar disorder (BD) is a common, highly heritable neuropsychiatric disease characterized by recurrent episodes of mania and depression. Lithium is the best-established long-term treatment for BD, even though individual response is highly variable. Evidence suggests that some of this variability has a genetic basis. This is supported by the largest genome-wide association study (GWAS) of lithium response to date conducted by the International Consortium on Lithium Genetics (ConLiGen). Recently, we performed the first genome-wide analysis of the involvement of miRNAs in BD and identified nine BD-associated miRNAs. However, it is unknown whether these miRNAs are also associated with lithium response in BD. In the present study, we therefore tested whether common variants at these nine candidate miRNAs contribute to the variance in lithium response in BD. Furthermore, we systematically analyzed whether any other miRNA in the genome is implicated in the response to lithium. For this purpose, we performed gene-based tests for all known miRNA coding genes in the ConLiGen GWAS dataset (n = 2,563 patients) using a set-based testing approach adapted from the versatile gene-based test for GWAS (VEGAS2). In the candidate approach, miR-499a showed a nominally significant association with lithium response, providing some evidence for involvement in both development and treatment of BD. In the genome-wide miRNA analysis, 71 miRNAs showed nominally significant associations with the dichotomous phenotype and 106 with the continuous trait for treatment response. A total of 15 miRNAs revealed nominal significance in both phenotypes with miR-633 showing the strongest association with the continuous trait (p = 9.80E-04) and miR-607 with the dichotomous phenotype (p = 5.79E-04). No association between miRNAs and treatment response to lithium in BD in either of the tested conditions withstood multiple testing correction. Given the limited power of our study, the investigation of miRNAs
- Published
- 2018
12. 813 TALEN-mediated inactivation of dominant-negative keratin alleles results in the formation of a stable functional cytoskeleton and phenotypic alleviation of epidermolytic ichthyosis
- Author
-
March, O.P., primary, Kocher, T., additional, Lettner, T., additional, Ablinger, M., additional, Lackner, N., additional, Hainzl, S., additional, Peking, P., additional, Aushev, M., additional, Koller, U., additional, and Reichelt, J., additional
- Published
- 2018
- Full Text
- View/download PDF
13. Genetic variants associated with response to lithium treatment in bipolar disorder: A genome-wide association study
- Author
-
Hou, L, Heilbronner, U, Degenhardt, F, Adli, M, Akiyama, K, Akula, N, Ardau, R, Arias, B, Backlund, L, Banzato, CEM, Benabarre, A, Bengesser, S, Bhattacharjee, AK, Biernacka, JM, Birner, A, Brichant-Petitjean, C, Bui, ET, Cervantes, P, Chen, GB, Chen, HC, Chillotti, C, Cichon, S, Clark, SR, Colom, F, Cousins, DA, Cruceanu, C, Czerski, PM, Dantas, CR, Dayer, A, Étain, B, Falkai, P, Forstner, AJ, Frisén, L, Fullerton, JM, Gard, S, Garnham, JS, Goes, FS, Grof, P, Gruber, O, Hashimoto, R, Hauser, J, Herms, S, Hoffmann, P, Hofmann, A, Jamain, S, Jiménez, E, Kahn, JP, Kassem, L, Kittel-Schneider, S, Kliwicki, S, König, B, Kusumi, I, Lackner, N, Laje, G, Landén, M, Lavebratt, C, Leboyer, M, Leckband, SG, Jaramillo, CAL, Macqueen, G, Manchia, M, Martinsson, L, Mattheisen, M, McCarthy, MJ, McElroy, SL, Mitjans, M, Mondimore, FM, Monteleone, P, Nievergelt, CM, Nöthen, MM, Ösby, U, Ozaki, N, Perlis, RH, Pfennig, A, Reich-Erkelenz, D, Rouleau, GA, Schofield, PR, Schubert, KO, Schweizer, BW, Seemüller, F, Severino, G, Shekhtman, T, Shilling, PD, Shimoda, K, Simhandl, C, Slaney, CM, Smoller, JW, Squassina, A, Stamm, T, Stopkova, P, Tighe, SK, Tortorella, A, Turecki, G, Volkert, J, Witt, S, Wright, A, Young, LT, Zandi, PP, Potash, JB, Depaulo, JR, Hou, L, Heilbronner, U, Degenhardt, F, Adli, M, Akiyama, K, Akula, N, Ardau, R, Arias, B, Backlund, L, Banzato, CEM, Benabarre, A, Bengesser, S, Bhattacharjee, AK, Biernacka, JM, Birner, A, Brichant-Petitjean, C, Bui, ET, Cervantes, P, Chen, GB, Chen, HC, Chillotti, C, Cichon, S, Clark, SR, Colom, F, Cousins, DA, Cruceanu, C, Czerski, PM, Dantas, CR, Dayer, A, Étain, B, Falkai, P, Forstner, AJ, Frisén, L, Fullerton, JM, Gard, S, Garnham, JS, Goes, FS, Grof, P, Gruber, O, Hashimoto, R, Hauser, J, Herms, S, Hoffmann, P, Hofmann, A, Jamain, S, Jiménez, E, Kahn, JP, Kassem, L, Kittel-Schneider, S, Kliwicki, S, König, B, Kusumi, I, Lackner, N, Laje, G, Landén, M, Lavebratt, C, Leboyer, M, Leckband, SG, Jaramillo, CAL, Macqueen, G, Manchia, M, Martinsson, L, Mattheisen, M, McCarthy, MJ, McElroy, SL, Mitjans, M, Mondimore, FM, Monteleone, P, Nievergelt, CM, Nöthen, MM, Ösby, U, Ozaki, N, Perlis, RH, Pfennig, A, Reich-Erkelenz, D, Rouleau, GA, Schofield, PR, Schubert, KO, Schweizer, BW, Seemüller, F, Severino, G, Shekhtman, T, Shilling, PD, Shimoda, K, Simhandl, C, Slaney, CM, Smoller, JW, Squassina, A, Stamm, T, Stopkova, P, Tighe, SK, Tortorella, A, Turecki, G, Volkert, J, Witt, S, Wright, A, Young, LT, Zandi, PP, Potash, JB, and Depaulo, JR
- Abstract
Background Lithium is a first-line treatment in bipolar disorder, but individual response is variable. Previous studies have suggested that lithium response is a heritable trait. However, no genetic markers of treatment response have been reproducibly identified. Methods Here, we report the results of a genome-wide association study of lithium response in 2563 patients collected by 22 participating sites from the International Consortium on Lithium Genetics (ConLiGen). Data from common single nucleotide polymorphisms (SNPs) were tested for association with categorical and continuous ratings of lithium response. Lithium response was measured using a well established scale (Alda scale). Genotyped SNPs were used to generate data at more than 6 million sites, using standard genomic imputation methods. Traits were regressed against genotype dosage. Results were combined across two batches by meta-analysis. Findings A single locus of four linked SNPs on chromosome 21 met genome-wide significance criteria for association with lithium response (rs79663003, p=1·37×10-8; rs78015114, p=1·31×10-8; rs74795342, p=3·31×10-9; and rs75222709, p=3·50×10-9). In an independent, prospective study of 73 patients treated with lithium monotherapy for a period of up to 2 years, carriers of the response-associated alleles had a significantly lower rate of relapse than carriers of the alternate alleles (p=0·03268, hazard ratio 3·8, 95% CI 1·1-13·0). Interpretation The response-associated region contains two genes for long, non-coding RNAs (lncRNAs), AL157359.3 and AL157359.4. LncRNAs are increasingly appreciated as important regulators of gene expression, particularly in the CNS. Confirmed biomarkers of lithium response would constitute an important step forward in the clinical management of bipolar disorder. Further studies are needed to establish the biological context and potential clinical utility of these findings. Funding Deutsche Forschungsgemeinschaft, National Institute of Mental Hea
- Published
- 2016
14. Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder
- Author
-
Hou, L, Bergen, SE, Akula, N, Song, J, Hultman, CM, Landén, M, Adli, M, Alda, M, Ardau, R, Arias, B, Aubry, JM, Backlund, L, Badner, JA, Barrett, TB, Bauer, M, Baune, BT, Bellivier, F, Benabarre, A, Bengesser, S, Berrettini, WH, Bhattacharjee, AK, Biernacka, JM, Birner, A, Bloss, CS, Brichant-Petitjean, C, Bui, ET, Byerley, W, Cervantes, P, Chillotti, C, Cichon, S, Colom, F, Coryell, W, Craig, DW, Cruceanu, C, Czerski, PM, Davis, T, Dayer, A, Degenhardt, F, Del Zompo, M, DePaulo, JR, Edenberg, HJ, Étain, B, Falkai, P, Foroud, T, Forstner, AJ, Frisén, L, Frye, MA, Fullerton, JM, Gard, S, Garnham, JS, Gershon, ES, Goes, FS, Greenwood, TA, Grigoroiu-Serbanescu, M, Hauser, J, Heilbronner, U, Heilmann-Heimbach, S, Herms, S, Hipolito, M, Hitturlingappa, S, Hoffmann, P, Hofmann, A, Jamain, S, Jiménez, E, Kahn, JP, Kassem, L, Kelsoe, JR, Kittel-Schneider, S, Kliwicki, S, Koller, DL, König, B, Lackner, N, Laje, G, Lang, M, Lavebratt, C, Lawson, WB, Leboyer, M, Leckband, SG, Liu, C, Maaser, A, Mahon, PB, Maier, W, Maj, M, Manchia, M, Martinsson, L, McCarthy, MJ, McElroy, SL, McInnis, MG, McKinney, R, Mitchell, PB, Mitjans, M, Mondimore, FM, Monteleone, P, Mühleisen, TW, Nievergelt, CM, Nöthen, MM, Novák, T, Nurnberger, JI, Nwulia, EA, Ösby, U, Hou, L, Bergen, SE, Akula, N, Song, J, Hultman, CM, Landén, M, Adli, M, Alda, M, Ardau, R, Arias, B, Aubry, JM, Backlund, L, Badner, JA, Barrett, TB, Bauer, M, Baune, BT, Bellivier, F, Benabarre, A, Bengesser, S, Berrettini, WH, Bhattacharjee, AK, Biernacka, JM, Birner, A, Bloss, CS, Brichant-Petitjean, C, Bui, ET, Byerley, W, Cervantes, P, Chillotti, C, Cichon, S, Colom, F, Coryell, W, Craig, DW, Cruceanu, C, Czerski, PM, Davis, T, Dayer, A, Degenhardt, F, Del Zompo, M, DePaulo, JR, Edenberg, HJ, Étain, B, Falkai, P, Foroud, T, Forstner, AJ, Frisén, L, Frye, MA, Fullerton, JM, Gard, S, Garnham, JS, Gershon, ES, Goes, FS, Greenwood, TA, Grigoroiu-Serbanescu, M, Hauser, J, Heilbronner, U, Heilmann-Heimbach, S, Herms, S, Hipolito, M, Hitturlingappa, S, Hoffmann, P, Hofmann, A, Jamain, S, Jiménez, E, Kahn, JP, Kassem, L, Kelsoe, JR, Kittel-Schneider, S, Kliwicki, S, Koller, DL, König, B, Lackner, N, Laje, G, Lang, M, Lavebratt, C, Lawson, WB, Leboyer, M, Leckband, SG, Liu, C, Maaser, A, Mahon, PB, Maier, W, Maj, M, Manchia, M, Martinsson, L, McCarthy, MJ, McElroy, SL, McInnis, MG, McKinney, R, Mitchell, PB, Mitjans, M, Mondimore, FM, Monteleone, P, Mühleisen, TW, Nievergelt, CM, Nöthen, MM, Novák, T, Nurnberger, JI, Nwulia, EA, and Ösby, U
- Abstract
Bipolar disorder (BD) is a genetically complex mental illness characterized by severe oscillations of mood and behaviour. Genome-wide association studies (GWAS) have identified several risk loci that together account for a small portion of the heritability. To identify additional risk loci, we performed a two-stage meta-analysis of > 9 million genetic variants in 9,784 bipolar disorder patients and 30,471 controls, the largest GWAS of BD to date. In this study, to increase power we used ~2,000 lithium-treated cases with a long-term diagnosis of BD from the Consortium on Lithium Genetics, excess controls, and analytic methods optimized for markers on the X-chromosome. In addition to four known loci, results revealed genome-wide significant associations at two novel loci: an intergenic region on 9p21.3 (rs12553324, P= 5.87×10-9; odds ratio (OR)=1.12) and markers within ERBB2 (rs2517959, P= 4.53×10-9; OR=1.13). No significant X-chromosome associations were detected and Xlinked markers explained very little BD heritability. The results add to a growing list of common autosomal variants involved in BD and illustrate the power of comparing well-characterized cases to an excess of controls in GWAS.
- Published
- 2016
15. Social cognition deficits in bipolar disorder – associations with overweight and obesity
- Author
-
Lackner, N., primary, Birner, A., additional, Bengesser, S.A., additional, Fellendorf, F.T., additional, Platzer, M., additional, Queissner, R., additional, Kapfhammer, H.P., additional, Reininghaus, B., additional, Weiss, E., additional, Wallner-Liebmann, S.J., additional, and Reininghaus, E.Z., additional
- Published
- 2016
- Full Text
- View/download PDF
16. Increased ratio of 3-hydroxykynurenine to kynurenine acid in bipolar disorder
- Author
-
Birner, A., primary, Platzer, M., additional, Bengesser, S.A., additional, Lackner, N., additional, Queissner, R., additional, Fellendorf, F., additional, Kainzbauer, N., additional, Pilz, R., additional, Hamm, C., additional, Rauch, P., additional, Reininghaus, B., additional, Mangge, H., additional, Fuchs, D., additional, Kapfhammer, H.P., additional, Schwarz, M., additional, and Reininghaus, E.Z., additional
- Published
- 2016
- Full Text
- View/download PDF
17. Der Einsatz von Neurofeedback bei Anorexia nervosa: ein Fallbeispiel
- Author
-
Lackner, N., additional, Unterrainer, H., additional, Skliris, D., additional, Wood, G., additional, Dunitz-Scheer, M., additional, Wallner-Liebmann, S., additional, Scheer, P., additional, and Neuper, C., additional
- Published
- 2016
- Full Text
- View/download PDF
18. Abdominal obesity is associated with impaired cognitive function in euthymic bipolar individuals
- Author
-
Lackner, N., primary, Bengesser, S.A., additional, Birner, A., additional, Painold, A., additional, Fellendorf, F.T., additional, Platzer, M., additional, Reininghaus, B., additional, Weiss, E.M., additional, Mangge, H., additional, McIntyre, R.S., additional, Fuchs, D., additional, Kapfhammer, H.P., additional, Wallner-Liebmann, S.J., additional, and Reininghaus, E.Z., additional
- Published
- 2015
- Full Text
- View/download PDF
19. The new ABC and further steps—innovative self-assessments and interventions for more efficient coping-strategies of people with bipolar disorders
- Author
-
Danner, U., primary, Macheiner, T., additional, Avian, A., additional, Gigler, C., additional, Bengesser, S., additional, Birner, A., additional, Lackner, N., additional, Platzer, M., additional, Kapfhammer, H.-P., additional, and Reininghaus, E., additional
- Published
- 2015
- Full Text
- View/download PDF
20. Clinical Implications of White Matter Lesions in Overweight Male Individuals with Bipolar Disorder
- Author
-
Birner, A., primary, Seiler, S., additional, Lackner, N., additional, Bengesser, S., additional, Queissner, R., additional, Platzer, M., additional, Fellendorf, F., additional, Pirpamer, L., additional, Ropele, S., additional, Enzinger, C., additional, Kapfhammer, H.P., additional, Reininghaus, B., additional, and Reininghaus, E., additional
- Published
- 2015
- Full Text
- View/download PDF
21. Food Craving in Bipolar Disorder
- Author
-
Lackner, N., primary, Platzer, M., additional, Fellendorf, F.T., additional, Rieger, A., additional, Schörkhuber, C., additional, Queissner, R., additional, Gatkowsky, K., additional, Birner, A., additional, Bengesser, S.A., additional, Unterweger, R., additional, Painold, A., additional, Reininghaus, B., additional, Weiss, E., additional, Wallner-Liebmann, S.J., additional, Kapfhammer, H.P., additional, and Reininghaus, E.Z., additional
- Published
- 2015
- Full Text
- View/download PDF
22. Is the Molecular Clock Ticking Differently in Bipolar Disorder?
- Author
-
Bengesser, S., primary, Lackner, N., additional, Birner, A., additional, Reininghaus, B., additional, Heilbronner, U., additional, Fuchs, R., additional, Allard, N., additional, Wallner-Liebmann, S., additional, Rieger, A., additional, Queissner, R., additional, Filic, K., additional, Fellendorf, F., additional, Petek, E., additional, Windpassinger, C., additional, Schörkhuber, C., additional, Gigler, C., additional, Gatkowsky, K., additional, Macheiner, T., additional, Kainzbauer, N., additional, and Reininghaus, E., additional
- Published
- 2015
- Full Text
- View/download PDF
23. Rapid Cycling – Endlich stabil aber adipös – Ziel erreicht?
- Author
-
Reininghaus, B., additional, Bengesser, S., additional, Reininghaus, E., additional, Lackner, N., additional, Kapfhammer, H., additional, and Birner, A., additional
- Published
- 2014
- Full Text
- View/download PDF
24. Pädiatrische Bipolare Störung – Kasuistik eines bipolaren Patienten mit Krankheitsbeginn im Kindes- und Jugendalter: Diagnostische und therapeutische Implikationen
- Author
-
Lackner, N., additional, Birner, A., additional, Bengesser, S., additional, Reininghaus, B., additional, Kapfhammer, H., additional, and Reininghaus, E., additional
- Published
- 2014
- Full Text
- View/download PDF
25. EPA-0444 – The role of staging in bipolar disorder - associations with overweight and obesity
- Author
-
Lackner, N., primary, Bengesser, S., additional, Birner, A., additional, Fellendorf, F., additional, Unterweger, R., additional, Wallner-Liebmann, S., additional, Kapfhammer, H.P., additional, and Reininghaus, E., additional
- Published
- 2014
- Full Text
- View/download PDF
26. EPA-0451 - Phenylalanine and tyrosine concentrations in euthymic bipolar disorder
- Author
-
Reininghaus, E., primary, McIntyre, R.S., additional, Lackner, N., additional, Bengesser, S.A., additional, Birner, A., additional, Fellendorf, F.T., additional, Kapfhammer, H.P., additional, Meinitzer, A., additional, Zelzer, S., additional, Wallner-Liebmann, S.J., additional, Mangge, H., additional, and Fuchs, D., additional
- Published
- 2014
- Full Text
- View/download PDF
27. EPA-0431 – Weight cycling and substance abuse in bipolar disorder
- Author
-
Fellendorf, F., primary, Lackner, N., additional, Bengesser, S., additional, Birner, A., additional, Platzer, M., additional, Filic, K., additional, Queissner, R., additional, Wallner-Liebmann, S., additional, Kapfhammer, H.P., additional, and Reininghaus, E.Z., additional
- Published
- 2014
- Full Text
- View/download PDF
28. P.2.d.046 - Increased ratio of 3-hydroxykynurenine to kynurenine acid in bipolar disorder
- Author
-
Birner, A., Platzer, M., Bengesser, S.A., Lackner, N., Queissner, R., Fellendorf, F., Kainzbauer, N., Pilz, R., Hamm, C., Rauch, P., Reininghaus, B., Mangge, H., Fuchs, D., Kapfhammer, H.P., Schwarz, M., and Reininghaus, E.Z.
- Published
- 2016
- Full Text
- View/download PDF
29. P.2.d.033 - Social cognition deficits in bipolar disorder – associations with overweight and obesity
- Author
-
Lackner, N., Birner, A., Bengesser, S.A., Fellendorf, F.T., Platzer, M., Queissner, R., Kapfhammer, H.P., Reininghaus, B., Weiss, E., Wallner-Liebmann, S.J., and Reininghaus, E.Z.
- Published
- 2016
- Full Text
- View/download PDF
30. P.2.d.041 The benefit of physical activity as a treatment of bipolar disorder
- Author
-
Oberreither, E., primary, Bengesser, S., additional, Lackner, N., additional, Fellendorf, F., additional, Mitteregger, A., additional, Kattnig, F., additional, Reininghaus, B., additional, Kapfhammer, H., additional, Liebmann-Wallner, S., additional, and Reininghaus, E., additional
- Published
- 2013
- Full Text
- View/download PDF
31. P.2.d.043 Mood stabilisation and oxidative stress parameters in bipolar disorder
- Author
-
Bengesser, S., primary, Lackner, N., additional, Oberreither, E., additional, Birner, A., additional, Liebmann-Wallner, S., additional, Zelzer, S., additional, Mangge, H., additional, Kapfhammer, H.P., additional, Reininghaus, B., additional, and Reininghaus, E., additional
- Published
- 2013
- Full Text
- View/download PDF
32. P.2.d.015 Cognitive deficits in obese bipolar patients – the impact of body fat distribution
- Author
-
Lackner, N., primary, Bengesser, S., additional, Birner, A., additional, Reininghaus, B., additional, Kattnig, F., additional, Fellendorf, F.T., additional, Mitteregger, A., additional, Oberreither, E., additional, Wallner-Liebmann, S.J., additional, Kapfhammer, H.P., additional, and Reininghaus, E.Z., additional
- Published
- 2013
- Full Text
- View/download PDF
33. Effekte von Neurofeedback auf klinische Persönlichkeitsakzentuierungen in der Therapie von Alkoholabhängigkeit
- Author
-
Lackner, N, primary, Lassacher, I, additional, Dunst, BM, additional, Novosel, A, additional, Unterrainer, HF, additional, Wallner-Liebmann, SJ, additional, and Neuper, C, additional
- Published
- 2013
- Full Text
- View/download PDF
34. Poststroke-Bipolar affektive Erkrankung
- Author
-
Bengesser, S., additional, Wurm, W., additional, Lackner, N., additional, Birner, A., additional, Reininghaus, B., additional, Kapfhammer, H.-P., additional, and Reininghaus, E., additional
- Published
- 2013
- Full Text
- View/download PDF
35. Bipolar affektive Störung und Compliance
- Author
-
Bengesser, S., additional, Reininghaus, B., additional, Birner, A., additional, Lackner, N., additional, Kapfhammer, H.-P., additional, and Reininghaus, E., additional
- Published
- 2013
- Full Text
- View/download PDF
36. Abdominal obesity is associated with impaired cognitive function in euthymic bipolar individuals.
- Author
-
Lackner, N., Bengesser, S.A., Birner, A., Painold, A., Fellendorf, F.T., Platzer, M., Reininghaus, B., Weiss, E.M., Mangge, H., McIntyre, R.S., Fuchs, D., Kapfhammer, H.P., Wallner-Liebmann, S.J., and Reininghaus, E.Z.
- Subjects
- *
OBESITY , *COGNITIVE ability , *BIPOLAR disorder , *CARDIOVASCULAR diseases , *QUALITY of life - Abstract
Objectives.Overweight/obesity has been implicated to play a role in cognitive deficits in bipolar disorder (BD). This study aims to identify the relationship between body fat distribution and different domains of cognition in BD during euthymia.Methods.A sample of 100 euthymic individuals with BD was measured with a cognitive test battery (i.e., Trail Making Test-A-B/TM-A/B, d2 Test of Attention, Stroop test, California Verbal Learning Test/CVLT) and an anthropometric measures set (body mass index, waist circumference, hip circumference, waist-to-hip-ratio, waist-to-height-ratio, and lipometry). Patient data were compared with a healthy control group (n =64).Results.Results show that overweight patients with BD exhibit lower performance in the TMT-A/B as well as in the free recall performance of the CVLT compared to normal-weight patients with BD and controls. In bipolar individuals, (abdominal) obesity was significantly associated with a poor cognitive performance. In bipolar females, associations with measures of verbal learning and memory were found; in bipolar males, associations with poor performance in the TMT-A/B and in the Stroop interference task were demonstrated. In controls, no associations were found.Conclusions.There are several possible pathways moderating the association between obesity and cognition in BD. Anthropometric and lipometry data underline the substantial mediating impact of body fat distribution on cognition in BD. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
37. The Impact of Neurofeedback-Training on the affective rating of different image categories in Anorexia Nervosa
- Author
-
Trinker, A, primary, Unterrainer, HF, additional, Lackner, N, additional, Novosel, A, additional, Dunitz-Scheer, M, additional, Scheer, PJ, additional, Skiliris, D, additional, Neuper, C, additional, and Wallner-Liebmann, SJ, additional
- Published
- 2012
- Full Text
- View/download PDF
38. Endoplasmic Reticulum Stress and Bipolar Disorder - Almost Forgotten Therapeutic Drug Targets in the Unfolded Protein Response Pathway Revisited
- Author
-
Sa, Bengesser, Fuchs R, Lackner N, Birner A, Reininghaus B, Meier-Allard N, Stracke A, Hp, Kapfhammer, Eva Reininghaus, and Wallner-Liebmann S
39. Pre-treatment with Trichoderma viride: Towards a better understanding of its consequences for anaerobic digestion.
- Author
-
Markt R, Prem EM, Lackner N, Mutschlechner M, Illmer P, and Wagner AO
- Subjects
- Anaerobiosis, Biofuels microbiology, RNA, Ribosomal, 16S genetics, Hydrolysis, Bacteria metabolism, Bacteria genetics, Bacteria classification, Bacteria isolation & purification, Hypocreales, Cellulose metabolism, Methane metabolism, Fermentation
- Abstract
Understanding and optimising biological pre-treatment strategies for enhanced bio-methane production is a central aspect in second-generation biofuel research. In this regard, the application of fungi for pre-treatment seems highly promising; however, understanding the mode of action is crucial. Here, we show how aerobic pre-treatment of crystalline cellulose with the cellulolytic Trichoderma viride affects substrate degradability during mesophilic, anaerobic digestion. It could be demonstrated that fungal pre-treatment resulted in a slightly reduced substrate mass. Nevertheless, no significant impact on the overall methane yield was found during batch fermentation. Short chain organic acids accumulation, thus, overall degradation dynamics including methane production kinetics were affected by the pre-treatment as shown by Gompertz modelling. Finally, 16S rRNA amplicon sequencing followed by ANCOM-BC resulted in up to 53 operative taxonomic units including fermentative, syntrophic and methanogenic taxa, whereby their relative abundances were significantly affected by fungal pre-treatment depending on the duration of the pre-treatment. The results demonstrated the impact of soft rot fungal pre-treatment of cellulose on subsequent anaerobic cellulose hydrolysis as well as on methanogenic activity. To the best of our knowledge, this is the first study to investigate the direct causal effects of pre-treatment with T. viride on basic but crucial anaerobic digestion parameters in a highly standardised approach., (© 2024 The Author(s). Environmental Microbiology Reports published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
40. Lithium response in bipolar disorder is associated with focal adhesion and PI3K-Akt networks: a multi-omics replication study.
- Author
-
Ou AH, Rosenthal SB, Adli M, Akiyama K, Akula N, Alda M, Amare AT, Ardau R, Arias B, Aubry JM, Backlund L, Bauer M, Baune BT, Bellivier F, Benabarre A, Bengesser S, Bhattacharjee AK, Biernacka JM, Cervantes P, Chen GB, Chen HC, Chillotti C, Cichon S, Clark SR, Colom F, Cousins DA, Cruceanu C, Czerski PM, Dantas CR, Dayer A, Del Zompo M, Degenhardt F, DePaulo JR, Étain B, Falkai P, Fellendorf FT, Ferensztajn-Rochowiak E, Forstner AJ, Frisén L, Frye MA, Fullerton JM, Gard S, Garnham JS, Goes FS, Grigoroiu-Serbanescu M, Grof P, Gruber O, Hashimoto R, Hauser J, Heilbronner U, Herms S, Hoffmann P, Hofmann A, Hou L, Jamain S, Jiménez E, Kahn JP, Kassem L, Kato T, Kittel-Schneider S, König B, Kuo PH, Kusumi I, Lackner N, Laje G, Landén M, Lavebratt C, Leboyer M, Leckband SG, Jaramillo CAL, MacQueen G, Maj M, Manchia M, Marie-Claire C, Martinsson L, Mattheisen M, McCarthy MJ, McElroy SL, McMahon FJ, Mitchell PB, Mitjans M, Mondimore FM, Monteleone P, Nievergelt CM, Nöthen MM, Novák T, Ösby U, Ozaki N, Papiol S, Perlis RH, Pisanu C, Potash JB, Pfennig A, Reich-Erkelenz D, Reif A, Reininghaus EZ, Rietschel M, Rouleau GA, Rybakowski JK, Schalling M, Schofield PR, Schubert KO, Schulze TG, Schweizer BW, Seemüller F, Severino G, Shekhtman T, Shilling PD, Shimoda K, Simhandl C, Slaney CM, Squassina A, Stamm T, Stopkova P, Tighe SK, Tortorella A, Turecki G, Vieta E, Volkert J, Witt S, Wray NR, Wright A, Young LT, Zandi PP, and Kelsoe JR
- Subjects
- Humans, Proto-Oncogene Proteins c-akt genetics, Phosphatidylinositol 3-Kinases genetics, Genome-Wide Association Study, Multiomics, Focal Adhesions, Lithium pharmacology, Lithium therapeutic use, Bipolar Disorder drug therapy, Bipolar Disorder genetics
- Abstract
Lithium is the gold standard treatment for bipolar disorder (BD). However, its mechanism of action is incompletely understood, and prediction of treatment outcomes is limited. In our previous multi-omics study of the Pharmacogenomics of Bipolar Disorder (PGBD) sample combining transcriptomic and genomic data, we found that focal adhesion, the extracellular matrix (ECM), and PI3K-Akt signaling networks were associated with response to lithium. In this study, we replicated the results of our previous study using network propagation methods in a genome-wide association study of an independent sample of 2039 patients from the International Consortium on Lithium Genetics (ConLiGen) study. We identified functional enrichment in focal adhesion and PI3K-Akt pathways, but we did not find an association with the ECM pathway. Our results suggest that deficits in the neuronal growth cone and PI3K-Akt signaling, but not in ECM proteins, may influence response to lithium in BD., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
41. COL7A1 Editing via RNA Trans -Splicing in RDEB-Derived Skin Equivalents.
- Author
-
Liemberger B, Bischof J, Ablinger M, Hainzl S, Murauer EM, Lackner N, Ebner P, Kocher T, Nyström A, Wally V, Mayr E, Guttmann-Gruber C, Hofbauer JP, Bauer JW, and Koller U
- Subjects
- Humans, Trans-Splicing, Skin metabolism, Keratinocytes metabolism, Collagen Type VII genetics, Mutation, Epidermolysis Bullosa Dystrophica genetics, Epidermolysis Bullosa genetics
- Abstract
Mutations in the COL7A1 gene lead to malfunction, reduction or complete absence of type VII collagen (C7) in the skin's basement membrane zone (BMZ), impairing skin integrity. In epidermolysis bullosa (EB), more than 800 mutations in COL7A1 have been reported, leading to the dystrophic form of EB (DEB), a severe and rare skin blistering disease associated with a high risk of developing an aggressive form of squamous cell carcinoma. Here, we leveraged a previously described 3'-RTMS6m repair molecule to develop a non-viral, non-invasive and efficient RNA therapy to correct mutations within COL7A1 via spliceosome-mediated RNA trans -splicing (SMaRT). RTM-S6m, cloned into a non-viral minicircle-GFP vector, is capable of correcting all mutations occurring between exon 65 and exon 118 of COL7A1 via SMaRT. Transfection of the RTM into recessive dystrophic EB (RDEB) keratinocytes resulted in a trans -splicing efficiency of ~1.5% in keratinocytes and ~0.6% in fibroblasts, as confirmed on mRNA level via next-generation sequencing (NGS). Full-length C7 protein expression was primarily confirmed in vitro via immunofluorescence (IF) staining and Western blot analysis of transfected cells. Additionally, we complexed 3'-RTMS6m with a DDC642 liposomal carrier to deliver the RTM topically onto RDEB skin equivalents and were subsequently able to detect an accumulation of restored C7 within the basement membrane zone (BMZ). In summary, we transiently corrected COL7A1 mutations in vitro in RDEB keratinocytes and skin equivalents derived from RDEB keratinocytes and fibroblasts using a non-viral 3'-RTMS6m repair molecule.
- Published
- 2023
- Full Text
- View/download PDF
42. Dual-energy CT evaluation of 3D printed materials for radiotherapy applications.
- Author
-
Fonseca GP, Rezaeifar B, Lackner N, Haanen B, Reniers B, and Verhaegen F
- Subjects
- Radiometry, Radiography, Phantoms, Imaging, Printing, Three-Dimensional, Tomography, X-Ray Computed, Radiation Oncology
- Abstract
Objective . There is a continuous increase in 3D printing applications in several fields including medical imaging and radiotherapy. Although there are numerous advantages of using 3D printing for the development of customized phantoms, bolus, quality assurance devices and other clinical applications, material properties are not well known and printer settings can affect considerably the properties (e.g. density, isotropy and homogeneity) of the printed parts. This study aims to evaluate several materials and printer properties to identify a range of tissue-mimicking materials. Approach . Dual-energy CT was used to obtain the effective atomic number ( Z
eff ) and relative electron density (RED) for thirty-one different materials including different colours of the same filament from the same manufacturer and the same type of filament from different manufacturers. In addition, a custom bone equivalent filament was developed and evaluated since a high-density filament with a composition similar to bone is not commercially available. Printing settings such as infill density, infill pattern, layer height and nozzle size were also evaluated. Main results . Large differences were observed for HU (288), RED (>10%) and Zeff (>50%) for different colours of the same filament due to the colour pigment. Results show a wide HU variation (-714 to 1104), RED (0.277 to 1.480) and Zeff (5.22 to 12.39) between the printed samples with some materials being comparable to commercial tissue-mimicking materials and good substitutes to a range of materials from lung to bone. Printer settings can result in directional dependency and significantly affect the homogeneity of the samples. Significance . The use of DECT to extract RED, and Zeff allows for quantitative imaging and dosimetry using 3D printed materials equivalent to certified tissue-mimicking tissues., (Creative Commons Attribution license.)- Published
- 2023
- Full Text
- View/download PDF
43. Expanding the Pathogen Panel in Wastewater Epidemiology to Influenza and Norovirus.
- Author
-
Markt R, Stillebacher F, Nägele F, Kammerer A, Peer N, Payr M, Scheffknecht C, Dria S, Draxl-Weiskopf S, Mayr M, Rauch W, Kreuzinger N, Rainer L, Bachner F, Zuba M, Ostermann H, Lackner N, Insam H, and Wagner AO
- Subjects
- Humans, Wastewater, SARS-CoV-2 genetics, Influenza, Human epidemiology, Norovirus genetics, COVID-19 epidemiology
- Abstract
Since the start of the 2019 pandemic, wastewater-based epidemiology (WBE) has proven to be a valuable tool for monitoring the prevalence of SARS-CoV-2. With methods and infrastructure being settled, it is time to expand the potential of this tool to a wider range of pathogens. We used over 500 archived RNA extracts from a WBE program for SARS-CoV-2 surveillance to monitor wastewater from 11 treatment plants for the presence of influenza and norovirus twice a week during the winter season of 2021/2022. Extracts were analyzed via digital PCR for influenza A, influenza B, norovirus GI, and norovirus GII. Resulting viral loads were normalized on the basis of NH
4 -N. Our results show a good applicability of ammonia-normalization to compare different wastewater treatment plants. Extracts originally prepared for SARS-CoV-2 surveillance contained sufficient genomic material to monitor influenza A, norovirus GI, and GII. Viral loads of influenza A and norovirus GII in wastewater correlated with numbers from infected inpatients. Further, SARS-CoV-2 related non-pharmaceutical interventions affected subsequent changes in viral loads of both pathogens. In conclusion, the expansion of existing WBE surveillance programs to include additional pathogens besides SARS-CoV-2 offers a valuable and cost-efficient possibility to gain public health information.- Published
- 2023
- Full Text
- View/download PDF
44. Multiple colony antifungal susceptibility testing detects polyresistance in clinical Candida cultures: a European Confederation of Medical Mycology excellence centers study.
- Author
-
Knoll MA, Lackner N, Ulmer H, Samardzic E, Steinmann J, Krause R, Verhasselt HL, Rath PM, Fuchs F, Koehler P, Denis B, Hamane S, Alanio A, and Lass-Flörl C
- Subjects
- Anidulafungin, Antifungal Agents pharmacology, Candida albicans, Drug Resistance, Fungal, Humans, Microbial Sensitivity Tests, Mycology, Candida genetics, Fluconazole pharmacology
- Abstract
Objectives: Many factors influence the outcome of in vitro antifungal susceptibility testing (AFST), including endpoint definition, inoculum sizes, time and temperature of incubation, and growth medium used. This European Confederation of Medical Mycology (ECMM) Excellence center driven study investigated multiple colony testing (MCT) of five separate colonies to investigate the prevalence of polyresistance (PR), defined as heterogeneous MICs from a same-species Candida culture irrespective of the underlying resistance mechanism., Methods: Candida spp. MCT for fluconazole and anidulafungin was performed by Etest prospectively comprising 405 clinical samples. MCT results were compared to the real-life routine MIC data and PR was assessed. Candida colonies displaying strong PR were selected for genotyping using multilocus sequence typing and random amplified polymorphic DNA assays for C. lusitaniae., Results: Candida PR was observed in 33 of 405 samples (8.1%), with higher rates for non-albicans species (26/186, 14%) than for C. albicans (7/219, 3.2%), and for fluconazole than for anidulafungin. MCT detected acquired resistance more often than routine AFST (18/405, 4.5%) and 9 of the 161 investigated blood cultures showed PR (5.6%). Multilocus sequence typing and random amplified polymorphic DNA did not reveal a uniform genetic correlate in strains studied., Conclusions: This study shows that Candida single MIC-values obtained in routine diagnostics may be incidental, as they fail to detect PR and resistant subpopulations reliably. The reasons for PR seem to be manifold and should be regarded as a phenotypical expression of genomic variability irrespective of the underlying resistance mechanism, which may help to interpret ambiguous and non-reproducible AFST results., (Copyright © 2022. Published by Elsevier Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
45. Technical note: Impact of beamline-specific particle energy spectra on clinical plans in carbon ion beam therapy.
- Author
-
Resch AF, Schafasand M, Lackner N, Niessen T, Beck S, Elia A, Boersma D, Grevillot L, Fossati P, Glimelius L, Stock M, Georg D, and Carlino A
- Subjects
- Carbon therapeutic use, Humans, Monte Carlo Method, Radiotherapy Planning, Computer-Assisted methods, Relative Biological Effectiveness, Water, Heavy Ion Radiotherapy methods
- Abstract
Purpose: The Local Effect Model version one (LEM I) is applied clinically across Europe to quantify the relative biological effectiveness (RBE) of carbon ion beams. It requires the full particle fluence spectrum differential in energy in each voxel as input parameter. Treatment planning systems (TPSs) use beamline-specific look-up tables generated with Monte Carlo (MC) codes. In this study, the changes in RBE weighted dose were quantified using different levels of details in the simulation or different MC codes., Methods: The particle fluence differential in energy was simulated with FLUKA and Geant4 at 500 depths in water in 1-mm steps for 58 initial carbon ion energies (between 120.0 and 402.8 MeV/u). A dedicated beam model was applied, including the full description of the Nozzle using GATE-RTionV1.0 (Geant4.10.03p03). In addition, two tables generated with FLUKA were compared. The starting points of the FLUKA simulations were phase space (PhS) files from, firstly, the Geant4 nozzle simulations, and secondly, a clinical beam model where an analytic approach was used to mimic the beamline. Treatment plans (TPs) were generated with RayStation 8B (RaySearch Laboratories AB, Sweden) for cubic targets in water and 10 clinical patient cases using the clinical beam model. Subsequently, the RBE weighted dose was re-computed using the two other fluence tables (FLUKA PhS or Geant4)., Results: The fluence spectra of the primary and secondary particles simulated with Geant4 and FLUKA generally agreed well for the primary particles. Differences were mainly observed for the secondary particles. Interchanging the two energy spectra (FLUKA vs. GEANT4) to calculate the RBE weighted dose distributions resulted in average deviations of less than 1% in the entrance up to the end of the target region, with a maximum local deviation at the distal edge of the target. In the fragment tail, larger discrepancies of up to 5% on average were found for deep-seated targets. The patient and water phantom cases demonstrated similar results., Conclusion: RBE weighted doses agreed well within all tested setups, confirming the clinical beam model provided by the TPS vendor. Furthermore, the results showed that the open source and generally available MC code Geant4 (in particular using GATE or GATE-RTion) can also be used to generate basic beam data required for RBE calculation in carbon ion therapy., (© 2022 The Authors. Medical Physics published by Wiley Periodicals LLC on behalf of American Association of Physicists in Medicine.)
- Published
- 2022
- Full Text
- View/download PDF
46. The glutamyl tail length of the cofactor F 420 in the methanogenic Archaea Methanosarcina thermophila and Methanoculleus thermophilus.
- Author
-
Wunderer M, Markt R, Lackner N, and Wagner AO
- Subjects
- Methane, Riboflavin analogs & derivatives, Methanomicrobiaceae enzymology, Methanosarcina enzymology
- Abstract
The cofactor F
420 is synthesized by many different organisms and as a redox cofactor, it plays a crucial role in the redox reactions of catabolic and biosynthetic metabolic pathways. It consists of a deazaflavin structure, which is linked via lactate to an oligoglutamate chain, that can vary in length. In the present study, the methanogenic Archaea Methanosarcina thermophila and Methanoculleus thermophilus were cultivated on different carbon sources and their coenzyme F420 composition has been assayed by reversed-phase ion-pair high-performance liquid chromatography with fluorometric detection regarding both, overall cofactor F420 production and distribution of F420 glutamyl tail length. In Methanosarcina thermophila cultivated on methanol, acetate, and a mixture of acetate and methanol, the most abundant cofactors were F420 -5 and F420 -4, whereby the last digit refers to the number of expressed glutamyl rests. By contrast, in the obligate CO2 reducing Methanoculleus thermophilus the most abundant cofactors were F420 -3 and F420 -4. In Methanosarcina thermophila, the relative proportions of the expressed F420 tail length changed during batch growth on all three carbon sources. Over time F420 -3 and F420 -4 decreased while F420 -5 and F420 -6 increased in their relative proportion in comparison to total F420 content. In contrast, in Methanoculleus thermophilus the relative abundance of the different F420 cofactors remained stable. It was also possible to differentiate the two methanogenic Archaea based on the glutamyl tail length of the cofactor F420 . The cofactor F420 -5 in concentrations >2% could only be assigned to Methanosarcina thermophila. In all four variants a trend for a positive correlation between the DNA concentration and the total concentration of the cofactor could be shown. Except for the variant Methanosarcinathermophila with acetate as sole carbon source the same could be shown between the concentration of the mcrA gene copy number and the total concentration of the cofactor., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
47. Echinocandins and Their Activity against Aspergillus terreus Species Complex: a Novel Agar Screening Method.
- Author
-
Lackner N, Vahedi-Shahandashti R, Jähnig S, Schönherr L, and Lass-Flörl C
- Subjects
- Agar, Aspergillus, Lipopeptides pharmacology, Microbial Sensitivity Tests, Antifungal Agents pharmacology, Echinocandins pharmacology
- Abstract
We evaluated the newly proposed agar screening method for echinocandin susceptibility testing of 144 Aspergillus section Terrei isolates compared with the Etest method. Both methods defined the isolates to be wild-type strains for anidulafungin and micafungin, with Etest minimal effective concentrations (MECs) of ≤0.004 mg/L. For caspofungin, the novel agar screening method identified 37 isolates to be caspofungin non-wild type based on their fluffy colony appearance on caspofungin agar. Etest MECs for caspofungin for these isolates were scattered widely from 0.002 to 0.750 mg/L, showing only partial accordance between the two methods.
- Published
- 2022
- Full Text
- View/download PDF
48. COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility.
- Author
-
Lackner N, Thomé C, Öfner D, Joannidis M, Mayerhöfer T, Arora R, Samardzic E, Posch W, Breitkopf R, and Lass-Flörl C
- Abstract
Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) raises concerns as to whether it contributes to an increased mortality. The incidence of CAPA varies widely within hospitals and countries, partly because of difficulties in obtaining a reliable diagnosis. We implemented a routine screening of respiratory specimens in COVID-19 ICU patients for Aspergillus species using culture and galactomannan (GM) detection from serum and/or bronchoalveolar lavages (BAL). Out of 329 ICU patients treated during March 2020 and April 2021, 23 (7%) suffered from CAPA, 13 of probable, and 10 of possible. In the majority of cases, culture, microscopy, and GM testing were in accordance with CAPA definition. However, we saw that the current definitions underscore to pay attention for fungal microscopy and GM detection in BALs, categorizing definitive CAPA diagnosis based on culture positive samples only. The spectrum of Aspergillus species involved Aspergillus fumigatus , followed by Aspergillus flavus , Aspergillus niger , and Aspergillus nidulans. We noticed changes in fungal epidemiology, but antifungal resistance was not an issue in our cohort. The study highlights that the diagnosis and incidence of CAPA is influenced by the application of laboratory-based diagnostic tests. Culture positivity as a single microbiological marker for probable definitions may overestimate CAPA cases and thus may trigger unnecessary antifungal treatment.
- Published
- 2022
- Full Text
- View/download PDF
49. Extraction of Cofactor F420 for Analysis of Polyglutamate Tail Length from Methanogenic Pure Cultures and Environmental Samples.
- Author
-
Markt R, Wunderer M, Prem EM, Mutschlechner M, Lackner N, and Wagner AO
- Subjects
- Anaerobiosis, Archaea, Bacteria metabolism, Methane metabolism, Sewage, Microbiota, Polyglutamic Acid metabolism
- Abstract
The cofactor F420 plays a central role as a hydride carrier in the primary and secondary metabolism of many bacterial and archaeal taxa. The cofactor is best known for its role in methanogenesis, where it facilitates thermodynamically difficult reactions. As the polyglutamate tail varies in length between different organisms, length profile analyses might be a powerful tool for distinguishing and characterizing different groups and pathways in various habitats. Here, the protocol describes the extraction and optimization of cofactor F420 detection by applying solid-phase extraction combined with high-performance liquid chromatography analysis independent of cultural or molecular biological approaches. The method was applied to gain additional information on the expression of cofactor F420 from microbial communities in soils, anaerobic sludge, and pure cultures and was evaluated by spiking experiments. Thereby, the study succeeded in generating different F420 tail-length profiles for hydrogenotrophic and acetoclastic methanogens in controlled methanogenic pure cultures as well as from environmental samples such as anaerobic digester sludge and soils.
- Published
- 2021
- Full Text
- View/download PDF
50. Detection and Stability of SARS-CoV-2 Fragments in Wastewater: Impact of Storage Temperature.
- Author
-
Markt R, Mayr M, Peer E, Wagner AO, Lackner N, and Insam H
- Abstract
SARS-CoV-2 wastewater epidemiology suffers from uncertainties concerning sample storage. We show the effect of the storage of wastewater on the detectable SARS-CoV-2 load. Storage at 4 °C for up to 9 days had no significant effect, while storage at -20 °C led to a significant reduction in gene copy numbers.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.